Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC100422641 (ENSG00000258750) is a pseudogene related to the STT3A gene, which encodes a catalytic subunit of the oligosaccharyltransferase (OST) complex. Unlike the functional STT3A gene, this locus is not believed to encode a functional protein. The STT3A gene itself is involved in N-glycosylation of proteins in the endoplasmic reticulum, but the pseudogene has no demonstrated biological or therapeutic role and is not a target for drug development[2]. Key clarification: - This entry is a pseudogene and not an active protein target or enzyme. - No evidence links LOC100422641 to disease, drug interaction, biomarker, or mechanism of action. - If you require information on the active, protein-coding form (STT3A), refer to ENSG00000134910[1]. The main point of confusion is that while "STT3A" itself refers to a valid and important target, "ENSG00000258750" / "LOC100422641" does NOT, as it is explicitly a pseudogene and not a gene product[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STT3A, subunit of the oligosaccharyltransferase complex, homolog A pseudogene (LOC100422641).